Details
Stereochemistry | UNKNOWN |
Molecular Formula | C11H18N2O.2ClH |
Molecular Weight | 267.195 |
Optical Activity | ( - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CC(C)NC(C)CC1=CC=C(O)C=N1
InChI
InChIKey=WWKMQPRSOJYBNS-UHFFFAOYSA-N
InChI=1S/C11H18N2O.2ClH/c1-8(2)13-9(3)6-10-4-5-11(14)7-12-10;;/h4-5,7-9,13-14H,6H2,1-3H3;2*1H
Molecular Formula | C11H18N2O |
Molecular Weight | 194.2734 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8410411
90, 200, or 600 mg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:11:38 GMT 2023
by
admin
on
Sat Dec 16 10:11:38 GMT 2023
|
Record UNII |
C3LFG625CK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76906-73-5
Created by
admin on Sat Dec 16 10:11:38 GMT 2023 , Edited by admin on Sat Dec 16 10:11:38 GMT 2023
|
PRIMARY | |||
|
C3LFG625CK
Created by
admin on Sat Dec 16 10:11:38 GMT 2023 , Edited by admin on Sat Dec 16 10:11:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> ENANTIOMER |
|
||
|
RACEMATE -> ENANTIOMER |